Ceriello A - Search Results

1

Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials.

Silverii GA, Monami M, Gallo M, Ragni A, Prattichizzo F, Renzelli V, Ceriello A, Mannucci E. Silverii GA, et al. Among authors: ceriello a. Diabetes Obes Metab. 2024 Mar;26(3):891-900. doi: 10.1111/dom.15382. Epub 2023 Nov 29. Diabetes Obes Metab. 2024. PMID: 38018310

2

Why is hyperglycaemia worsening COVID-19 and its prognosis?

Ceriello A, De Nigris V, Prattichizzo F. Ceriello A, et al. Diabetes Obes Metab. 2020 Oct;22(10):1951-1952. doi: 10.1111/dom.14098. Epub 2020 Jun 21. Diabetes Obes Metab. 2020. PMID: 32463166 Free PMC article. No abstract available.

3

Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios.

Prattichizzo F, de Candia P, De Nigris V, Nicolucci A, Ceriello A. Prattichizzo F, et al. Among authors: ceriello a. Metabolism. 2020 Sep;110:154308. doi: 10.1016/j.metabol.2020.154308. Epub 2020 Jul 4. Metabolism. 2020. PMID: 32628943

4

Positioning newer drugs in the management of type 2 diabetes.

Prattichizzo F, Ceriello A. Prattichizzo F, et al. Among authors: ceriello a. Lancet Diabetes Endocrinol. 2021 Mar;9(3):138-139. doi: 10.1016/S2213-8587(21)00022-X. Lancet Diabetes Endocrinol. 2021. PMID: 33607038 No abstract available.

5

Pharmacological management of COVID-19 in type 2 diabetes.

Ceriello A, Prattichizzo F. Ceriello A, et al. J Diabetes Complications. 2021 Jul;35(7):107927. doi: 10.1016/j.jdiacomp.2021.107927. Epub 2021 Apr 17. J Diabetes Complications. 2021. PMID: 33896714 Free PMC article. Review.

6

Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: A sistematic review and meta-analysis.

Prattichizzo F, de Candia P, Nicolucci A, Ceriello A. Prattichizzo F, et al. Among authors: ceriello a. Diabetes Metab Res Rev. 2022 Jan;38(1):e3476. doi: 10.1002/dmrr.3476. Epub 2021 May 28. Diabetes Metab Res Rev. 2022. PMID: 34018307 Free PMC article.

7

Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists.

Prattichizzo F, de Candia P, Ceriello A. Prattichizzo F, et al. Among authors: ceriello a. Metabolism. 2021 Jul;120:154799. doi: 10.1016/j.metabol.2021.154799. Epub 2021 May 23. Metabolism. 2021. PMID: 34029597 Review.

8

Is time ready for combination therapy at diagnosis of type 2 diabetes?

Prattichizzo F, Ceriello A. Prattichizzo F, et al. Among authors: ceriello a. Diabetes Metab Res Rev. 2021 Jul;37(5):e3460. doi: 10.1002/dmrr.3460. Diabetes Metab Res Rev. 2021. PMID: 34240524

9

Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists.

Uccellatore A, Genovese S, Dicembrini I, Mannucci E, Ceriello A. Uccellatore A, et al. Among authors: ceriello a. Diabetes Ther. 2015 Sep;6(3):239-56. doi: 10.1007/s13300-015-0127-x. Epub 2015 Aug 14. Diabetes Ther. 2015. PMID: 26271795 Free PMC article.

10

A Review of the Long-Term Efficacy, Tolerability, and Safety of Exenatide Once Weekly for Type 2 Diabetes.

Genovese S, Mannucci E, Ceriello A. Genovese S, et al. Among authors: ceriello a. Adv Ther. 2017 Aug;34(8):1791-1814. doi: 10.1007/s12325-017-0499-6. Epub 2017 Jul 3. Adv Ther. 2017. PMID: 28674957 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

607 results

Search Page